SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000891092-16-019320
Filing Date
2016-12-05
Accepted
2016-12-02 17:47:11
Documents
1
Group Members
JEREMY MINDICHMATTHEW SIROVICHSCOPIA CAPITAL GP LLCSCOPIA CAPITAL MANAGEMENT LPSCOPIA MANAGEMENT, INC.SCOPIA PX INTERNATIONAL MASTER FUND LPSCOPIA PX LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G e72146_sc13g-a.htm SC 13G/A 239172
  Complete submission text file 0000891092-16-019320.txt   241393
Mailing Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019 212-370-0303
SCOPIA CAPITAL MANAGEMENT LP (Filed by) CIK: 0001279150 (see all company filings)

IRS No.: 300711986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-85739 | Film No.: 162032231
SIC: 2834 Pharmaceutical Preparations